Rede Wealth, LLC Abbott Laboratories Transaction History

Rede Wealth, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Jul 21, 2022	BUY	$102.07 - $123.37 $204 - $246	2 Added 0.1%	2,057 $224,000
Q1 2022 Apr 18, 2022	BUY	$114.02 - $139.04 $228 - $278	2 Added 0.1%	2,055 $244,000
Q4 2021 Feb 07, 2022	BUY	$115.53 - $141.46 $11,668 - $14,287	101 Added 5.17%	2,053 $289,000
Q3 2021 Oct 08, 2021	SELL	$116.66 - $129.06 $11,432 - $12,647	-98 Reduced 4.78%	1,952 $231,000
Q2 2021 Jul 22, 2021	BUY	$105.79 - $124.53 $10,684 - $12,577	101 Added 5.18%	2,050 $235,000
Q1 2021 May 12, 2021	BUY	$108.84 - $128.23 $212,129 - $249,920	1,949 New	1,949 $234,000

3,185

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $207B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Rede Wealth, LLC, based on Form 13F filings with the SEC.

Stay updated on Rede Wealth, LLC with notifications on news.